The Management of Oral Anticoagulant Therapy: The Patient’s Point of View

Summary

The aims of this study were to investigate on the general adhesion of the patients to oral anticoagulant therapy, and particularly on the quality of life of our patients, the doctor-patient relationship and the Centre-patient relationship. For this purpose we administered a questionnaire containing 17 main questions each with a maximum of 4 secondary questions. The questionnaire was administered to two groups of 127 and 137 oral anticoagulated patients (127 males and 137 females, mean age 55 ± 19 years), followed at two Anticoagulation Clinics, in two Italian cities, Cagliari (Sardinia) and Padua (North East Italy). The cities differed in the number of patients monitored and the management modalities of anticoagulation. The results show that oral anticoagulant therapy does not limit the life-style of the patients. Only 11% of the patients complain of limitations to their daily life. Fifty-two percent believe their health has improved, and 87% are not afraid of negative consequences. The doctor-patient relationship is considered very important by 96% of patients. Seventy-eight percent refer to the Anticoagulation Clinic also for other health problems, 93% consider it important to be assessed by the doctor at the Anticoagulation Clinic, while 83% believe the doctor should always hand out the results personally. We conclude that in general oral anticoagulant therapy is accepted by the majority of patients, in spite of the need for periodic monitoring. The doctor-patient relationship should be taken into account, even in the case of a monitored, computer-assisted method of dose-adjustment.

Keywords

Oral anticoagulants - quality of life - anticoagulation clinic

• References

• 1 Hirsh J. Oral anticoagulant drugs. N Eng J Med 1991; 324: 1865-75.
• 2 Haemostasis and Thrombosis Task Force for the British Committee for Standards in Haematology. Guideline Guidelines on oral anticoagulation: third edition. Br J Haematol 1998; 101: 374-87.
• 3 Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994; 121: 676-83.
• 4 Marongiu F, Sorano GG, Conti M, Mameli G, Biondi G, Licheri D, Balestrieri A. Known vitamin K intake and management of poorly controlled oral anticoagulant therapy. Lancet 1992; 340: 545-6.
• 5 Kumar S, Haigh JRM, Rhodes LE, Peaker S, Davies JA, Roberts BE, Feely MP. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 1989; 62: 729-32.
• 6 Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med 1997; 103: 11-7.
• 7 Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993; 69: 316-20.
• 8 Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158: 1641-7.
• 9 Lancaster TR, Singer DE, Sheehan MA, Oertel LB, Maraventano SW, Hughes RA, Kistler JP. The impact of long-term warfarin therapy on quality of life Evidence from a randomised trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med 1991; 151: 1944-9.
• 10 Clayton D, Hills M. Statistical models in Epidemilogy. Oxford: Oxford Science: Publications Oxford; 1993
• 11 Federazione Centri Sorveglianza Anticoagulati (FCSA). A guide to oral anticoagulant therapy. Haemostasis 1998; 28 S1 1-46.
• 12 Sorano GG, Biondi G, Conti M, Mameli G, Licheri D, Marongiu F. Controlled vitamin K content diet for improving the management of poorly controlled anticoagulated patients: a clinical practise proposal. Haemostasis 1993; 23: 77-82.
• 13 Sawichi PT. A structured teaching and self-management program for patients receiving oral anticoagulation A randomised controlled trial. JAMA 1999; 281: 145-50.
• 14 Wenzel T, Morsdorf S, Sibitz I, Schenck JF, Griengl H, Erdlenbruch W, Heinrich W, Krischek B, Birner P, Harenberg J. Dimensions of quality of life and self-monitoring therapy with oral anticoagulants-Still research or everyday practice?. Sem Thromb Haemost 1999; 25: 117-21.
• 15 Ansell JE, Hughes R. Evolving models of warfarin management: Anticoagulation clinics, patients self-monitoring, and patient self-management. Am Heart J 1996; 132: 1095-100.
• 16 Poller L, Shiac CR, MacCallum PK, Johansen AM, Munster AM, Magalhaes A, Jespersen J. Multicentre randomised study of computerised anticoagulant dosage European Concerted Action on Anticoagulation. Lancet 1998; 352: 1505-9.
• 17 Barcellona D, Vannini ML, Fenu L, Balestrieri C, Marongiu F. Warfarin or acenocoumarol: which is better in the management of oral anticoagulant therapy?. Thromb Haemost 1998; 80: 899-902.